logo
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21

NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21

Globe and Mail21-05-2025
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies invited to present at the high-profile event, which is expected to draw more than 1,000 attendees representing over $1 trillion in investment capital.
The presentation will highlight the company's progress toward FDA approval of NRX-100, a preservative-free intravenous ketamine formulation, as well as its strategic acquisition plans for HOPE clinics focused on treating suicidal depression, PTSD, and related conditions.
To view the full press release, visit https://ibn.fm/eYj6T
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
For more information, please visit https://www.nrxpharma.com/
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
Corporate Communications
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CoreWeave Announces Multi-Billion Dollar Commitment to AI Infrastructure in Pennsylvania
CoreWeave Announces Multi-Billion Dollar Commitment to AI Infrastructure in Pennsylvania

Globe and Mail

time21 minutes ago

  • Globe and Mail

CoreWeave Announces Multi-Billion Dollar Commitment to AI Infrastructure in Pennsylvania

CoreWeave (NASDAQ: CRWV), the AI Hyperscaler™, today announced its intent to commit up to $6 billion to equip a new, state-of-the-art data center in Lancaster, Pennsylvania, purpose-built to power the most cutting-edge AI use cases. The initial 100 megawatt (MW) data center, with potential to expand to 300 MW, represents one of the first large-scale data centers of its kind in the region and will support US global competitiveness in AI. The announcement will be made during the CEO roundtable with President Donald J. Trump at Senator Dave McCormick's inaugural Pennsylvania Energy and Innovation Summit, hosted at Carnegie Mellon University in Pittsburgh. The event will include Pennsylvania Governor Josh Shapiro, Senator John Fetterman, as well as national and state leaders, policymakers, industry leaders and innovators, with the aim of shaping the future of US AI infrastructure, energy, job creation, long term national competitiveness and national security through high-impact emerging technologies. 'The demand for high-performance AI compute is relentless, and CoreWeave is scaling a cloud purpose-built for AI to meet it and strengthen US leadership,' said Michael Intrator, Co-Founder, Chairman of the Board, and Chief Executive Officer of CoreWeave. 'This data center will accelerate innovation and drive economic growth across the region. We look forward to working with leaders like Senator McCormick and Governor Shapiro to ensure this investment delivers meaningful, lasting impact.' 'I'm thrilled to welcome this transformative investment in our great Commonwealth,' said Senator Dave McCormick. 'This Energy and Innovation Summit is a powerful testament to Pennsylvania's readiness and ability to lead—to generate thousands of good-paying jobs, to unleash our incredible energy resources, and to power the next AI and economic revolution, further strengthening America's resilience and independence. I'm deeply grateful to CoreWeave for their tremendous commitment to Pennsylvania's future.' 'Pennsylvania is competing again and bringing in billions of dollars in new investment to the Commonwealth to support our technology sector, and CoreWeave's $6 billion investment will continue to build on that work — creating good-paying jobs as Pennsylvania workers build, maintain, and operate a new AI data center in Lancaster County,' said Governor Josh Shapiro. 'My Administration is leading the way on safe, responsible, and effective use of artificial intelligence – while keeping people at the center of Pennsylvania's AI strategy,' said Governor Shapiro. 'We are ensuring our Commonwealth is open to the major investments like this one from CoreWeave by investing in our workforce, building out more energy resources, securing funding for site development, speeding up the Commonwealth's permitting, licensing, and certification processes, and working to make sure Pennsylvania continues to be a national energy leader. With this commitment, CoreWeave is creating opportunities for our workers, generating new revenue for our local communities, and ensuring the future of AI runs right through Pennsylvania." Equipped with state-of-the-art infrastructure tailored for advanced AI workloads, the Lancaster data center will help position Pennsylvania, and the broader Mid-Atlantic region, as a strategic hub for the global AI economy. The project is expected to create approximately 600 skilled, competitively waged jobs during the build phase, with approximately 70 full-time technical and operational roles at launch, and scaling to approximately 175 over time. It is estimated that each data center job generates over six additional American jobs, amplifying the project's economic impact. 1 The Lancaster data center is the result of CoreWeave's ongoing engagement with policymakers at all levels who share a commitment to strengthening America's AI and energy system through vital investments in US-based infrastructure and policies that enable innovation. CoreWeave will be the tenant of the site, co-developed by Chirisa Technology Parks and Machine Investment Group. The companies will partner on all facets of workforce recruitment and community engagement, establishing a model for regional AI infrastructure that delivers long-term economic growth and community impact. CoreWeave is committed to investing in future-ready AI infrastructure hubs where they are needed most, across America's critical economic corridors, like the Mid-Atlantic, which this site will serve. The Lancaster facility will add to CoreWeave's growing network of 33 AI data centers, including 28 located across the U.S. ABOUT COREWEAVE CoreWeave, the AI Hyperscaler™, delivers a cloud platform of cutting-edge software powering the next wave of AI. The company's technology provides enterprises and leading AI labs with cloud solutions for accelerated computing. Since 2017, CoreWeave has operated a growing footprint of data centers across the US and Europe. CoreWeave was ranked as one of the TIME100 most influential companies and featured on Forbes Cloud 100 ranking in 2024. Learn more at 1 PwC, 'Economic Contributions of Data Centers in the United States,' February 2025.

3 Scorching-Hot Artificial Intelligence (AI) Stocks That Can Plunge Up to 72%, According to Select Wall Street Analysts
3 Scorching-Hot Artificial Intelligence (AI) Stocks That Can Plunge Up to 72%, According to Select Wall Street Analysts

Globe and Mail

time2 hours ago

  • Globe and Mail

3 Scorching-Hot Artificial Intelligence (AI) Stocks That Can Plunge Up to 72%, According to Select Wall Street Analysts

Key Points Artificial intelligence (AI) is a potential $15.7 trillion addressable market by the turn of the decade. Though Wall Street analysts are, collectively, optimistic about AI stocks, not all AI stocks are necessarily worth buying. Three red-hot AI stocks aren't as bulletproof as investors think, with select analysts forecasting downside ranging from 31% to 72% over the next year. 10 stocks we like better than Palantir Technologies › In the mid-1990s, the advent and proliferation of the internet revolutionized corporate America by opening new sales channels and creating connections that hadn't previously existed. Since the internet, investors have been patiently waiting for the next-big-thing technology to provide a true leap forward for corporate America. The arrival of artificial intelligence (AI) looks to be the answer. AI provides a way for empowered software and systems to make split-second decisions without the need for human oversight or intervention. In Sizing the Prize, the analysts at PwC pegged this global game-changing opportunity at $15.7 trillion (with a "t") by 2030. While sentiment on Wall Street and among analysts has been mostly bullish -- as you'd expect with a $15.7 trillion addressable market -- not every AI stock is necessarily worth buying. According to select Wall Street analysts, three of the market's scorching-hot AI stocks could plunge by as much as 72% over the next year. Palantir Technologies: Implied downside of 72% Though graphics processing unit (GPU) titan Nvidia is the face of the AI movement, arguably no company has come closer to dethroning it than AI and machine learning-driven data-mining specialist Palantir Technologies (NASDAQ: PLTR). Shares of Palantir have soared more than 2,100% since 2023 began, equating to an increase in market value of around $320 billion. The primary reason investors have gravitated to Palantir is its sustainable moat. Its Gotham platform, which secures multiyear contracts from the U.S. government and its immediate allies to collect/analyze data and assist with military mission planning and execution, is irreplaceable. Meanwhile, its Foundry platform, which is designed to help businesses make sense of their data in order to streamline their operations, has no large-scale one-for-one replacement. However, this sustainable moat isn't enough to impress longtime bear Rishi Jaluria at RBC Capital Markets. Although Jaluria nearly quadrupled his price target on the company from $11 to $40 earlier this year, a $40 bullseye would represent 72% downside from the $142.10 per share Palantir stock closed at on July 11. Jaluria's main issue with Palantir stock is something I've harped on repeatedly in recent weeks: its valuation. Prior to the dot-com bubble, many of Wall Street's cutting-edge companies topped out at price-to-sales (P/S) ratios of 31 to 43. Palantir ended the previous week at a P/S ratio of almost 114! No megacap stock in history, to my knowledge, has been able to sustain a valuation this aggressive -- even those with well-defined competitive advantages. Even the slightest operating slip-up or negative news from the U.S. government could clobber Palantir stock. Jaluria also cautioned that Foundry takes too tailored of an approach with its clients, which will hamper its ability to scale. The same can also be said for Gotham, which is only available to the U.S. and its immediate allies. In other words, Palantir stock is on shakier ground than its skyrocketing share price implies. Super Micro Computer: Implied downside of 51% Another red-hot AI stock that has the potential to be pummeled over the next 12 months is customizable rack server and storage solutions specialist Super Micro Computer (NASDAQ: SMCI). Shares of Supermicro are up 62% year-to-date (through July 11) and more than 1,100% on a trailing-three-year basis. The reason it's been a magnet for AI bulls is its role as a provider of customizable rack servers for AI-accelerated data centers. Businesses are aggressively spending on data center infrastructure to gain a competitive edge, and Supermicro's reliance on Nvidia's highly popular AI-GPUs in its rack servers has allowed its servers to sell like hotcakes. Following sales growth of 110% in fiscal 2024 (its fiscal year ends on June 30), Wall Street is forecasting 48% sales growth for fiscal 2025 and another 34% the following year. None of these figures have been enough to dazzle analyst Michael Ng of Goldman Sachs, who rates Super Micro Computer a sell and expects its shares will fall to $24, equating to 51% downside from where they ended the previous week. Ng's skepticism derives from a belief that the AI server market is becoming highly competitive, which is leading less differentiation and, ultimately, weaker pricing power. Ng anticipates Supermicro's gross profit margin will decline throughout the decade, even as sales potentially climb. Though not specifically mentioned by Ng, Super Micro Computer must also overcome a loss of trust with the investing community following allegations of wrongdoing last summer. While an independent committee absolved insiders of any wrongdoing and didn't result in any changes to the company's reported financial statements, it challenged investors' trust in the management team and squashed any chance of Supermicro commanding much of a valuation premium. Even though Supermicro's stock may appear cheap at just 17 times forward-year earnings, there are reasons investors are leery about giving its shares too much of a premium. SoundHound AI: Implied downside of 31% Lastly, AI voice recognition and conversational technologies stock SoundHound AI (NASDAQ: SOUN) can plunge over the coming year, based on the prognostication of one Wall Street analyst. Growth has not been an issue for this up-and-coming AI applications company. Sales for the March-ended quarter jumped 151% to $29.1 million from the prior-year period. This speaks to the company's ability to win new clients in the restaurant, automotive, travel and hospitality, and financial service industries, as well as tie these ecosystems together. Despite SoundHound AI decisively pointing its revenue needle in the right direction, Northland Securities analyst Michael Latimore foresees its stock plummeting to $8 over the next 12 months, which works out to a decline of 31%. Whereas the prior two analysts are decisively negative on Palantir and Supermicro, this isn't the case with Latimore and SoundHound AI. Latimore has a hold rating on the company and is excited about the agentic AI opportunities that lie ahead. The reason price targets should be kept in check is that SoundHound AI has a long way to go before it demonstrates to Wall Street that its operating model can generate profits. Excluding adjustments to contingent acquisition liabilities during the March-ended quarter, its adjusted loss actually widened from $20.2 million to $22.3 million, in spite of 151% growth in net sales from the prior-year quarter. SoundHound AI also burned through close to $19.1 million in cash from its operating activities. The company isn't expected to push into the recurring profit column until 2027, at the earliest. SoundHound AI would also be heavily exposed if an AI bubble formed and burst. Every next-big-thing technology for more than three decades has navigated its way through an early stage bubble, and nothing suggests artificial intelligence is going to be the exception to this unwritten rule. If demand for AI applications even remotely slows, SoundHound AI stock, which is valued at 23 times forward-year sales estimates, will feel the pain. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 14, 2025

3 Absurdly Cheap Growth Stocks to Load Up On Right Now
3 Absurdly Cheap Growth Stocks to Load Up On Right Now

Globe and Mail

time2 hours ago

  • Globe and Mail

3 Absurdly Cheap Growth Stocks to Load Up On Right Now

Key Points Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher. They all trade at forward price-to-earnings multiples of 17 or less. 10 stocks we like better than Novo Nordisk › Buying stocks that are trading at cheap valuations can set you up for some big gains later on. And it can minimize the risk of a decline if the market starts to struggle. Although many stocks look expensive today, there are three growth stocks which still seem absurdly cheap right now: Novo Nordisk (NYSE: NVO), PayPal (NASDAQ: PYPL), and Dell Technologies (NYSE: DELL). By investing in these companies, you can gain exposure to some top businesses, while also diversifying your portfolio. Here's a closer look at why each of these stocks can be a good long-term investment. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Novo Nordisk Drugmaker Novo Nordisk is a terrific healthcare company to consider investing in. The market has been bearish on it over the past year, as recent results from clinical trials haven't met expectations; there are also new concerns that tariffs on pharmaceuticals may weigh down Novo Nordisk and similar stocks. But as concerning as these developments may be, they're also short-term in nature. Novo Nordisk has been a growth-focused business for decades, and some solid products in its portfolio, including Wegovy and Ozempic, have enabled it to generate strong results in recent quarters and put it on track for even more growth in the future. Through the first three months of the year, the company grew its sales by 19% and its operating profit by 22%. The company is a big-name player in the market for GLP-1 medications. And if you invest in it today, you can get it for a modest forward price-to-earnings (P/E) multiple of 17. That's based on analyst estimates, but it gives you a good idea of how cheap the stock is -- the average stock in the S&P 500 trades at a forward P/E of 24. With its encouraging growth prospects, Novo Nordisk could be a no-brainer buy at its current valuation. PayPal A fintech company that doesn't seem to get enough love these days is PayPal. There are certainly concerns that growing competition will chip away at its growth, but its payment platform remains a top choice for customers and vendors to rely on. Its share of the global payments market remains at 45%, making it the top option, despite a flurry of other ways to pay. The company also has its own stablecoin, PayPal USD, so it can potentially leverage opportunities in the crypto space. Growth has been underwhelming of late, as sales through the first three months of the year totaled $7.8 billion, an increase of just 1% year over year. However, the economy is contending with rising costs and tariffs, so consumers scaling back on spending may have more to do with that slowdown than anything PayPal is doing. It's far too early to count PayPal out as a top growth stock: There's still a lot of room for it to grow, especially with PayPal USD in the mix, and its Venmo app is rising in popularity as well. At a forward P/E of only 15, this is an even cheaper stock to own than Novo Nordisk. Dell Technologies Computer maker Dell Technologies isn't doing well with the consumer market this year, but sales of servers have been strong, especially as companies invest heavily in artificial intelligence (AI). For its current fiscal year (which ends in January), Dell projects that its AI server sales will top $15 billion, an increase from the $10 billion total in the previous year. Dell is well positioned to take advantage of AI trends both in the business market and in the consumer market, through the sales of AI computers and servers. While sales of AI computers aren't taking off just yet, it may only be a matter of time before an upgrade cycle takes place, especially as consumers look to take advantage of next-gen computing capabilities. In its most recent quarter, which ended on May 2, Dell's revenue rose by a modest 5% to $23.4 billion. But if not for a 19% decline in its consumer segment, those numbers would have been much better. Dell is a trusted computer manufacturer and it's doing well, even if its operations aren't firing on all cylinders. At a forward P/E of less than 14, this is the cheapest stock on this list. With loads of potential in AI and other computing, Dell may be one of the better growth stocks to buy right now. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 14, 2025 David Jagielski has positions in Novo Nordisk. The Motley Fool has positions in and recommends PayPal. The Motley Fool recommends Novo Nordisk and recommends the following options: long January 2027 $42.50 calls on PayPal and short June 2025 $77.50 calls on PayPal. The Motley Fool has a disclosure policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store